← Back to headlines
Emergent BioSolutions Targets $720M–$760M Revenue by 2026 Amid Transformation Plan
Emergent BioSolutions has outlined a revenue target of $720 million to $760 million for 2026, as the company continues to advance its ongoing transformation plan.
27 Feb, 04:58 — 27 Feb, 04:58
ℹOnly 1 source covers this story



